Sarcopenia as a prognostic factor among patients with stage III melanoma. - Wikidata - awgldk - TriplyDB

Sarcopenia as a prognostic factor among patients with stage III melanoma.

Sarcopenia as a prognostic factor among patients with stage III melanoma.

http://www.wikidata.org/entity/Q37913089

about

Muscle dysfunction in cancer patients Sarcopenia and sarcopenic obesity: do they predict inferior oncologic outcomes after gastrointestinal cancer surgery?The impact of sarcopenia on survival and complications in surgical oncology: A review of the current literature A comparative study of software programmes for cross-sectional skeletal muscle and adipose tissue measurements on abdominal computed tomography scans of rectal cancer patients A Low Psoas Muscle Index before Treatment Can Predict a Poorer Prognosis in Advanced Bladder Cancer Patients Who Receive Gemcitabine and Nedaplatin Therapy Inflammation based regulation of cancer cachexia The Association of Computed Tomography-Assessed Body Composition with Mortality in Patients with Necrotizing Pancreatitis Age as a predictor of sentinel node metastasis among patients with localized melanoma: an inverse correlation of melanoma mortality and incidence of sentinel node metastasis among young and old patients.Sarcopenia as a prognostic biomarker of advanced urothelial carcinoma Measurement of skeletal muscle radiation attenuation and basis of its biological variation.Sarcopenia adversely impacts postoperative complications following resection or transplantation in patients with primary liver tumors Pre-operative assessment of muscle mass to predict surgical complications and prognosis in patients with endometrial cancer Negative Impact of Skeletal Muscle Loss after Systemic Chemotherapy in Patients with Unresectable Colorectal Cancer Skeletal muscle radio-density is an independent predictor of response and outcomes in follicular lymphoma treated with chemoimmunotherapy.Skeletal muscle depletion predicts the prognosis of patients with hepatocellular carcinoma treated with sorafenib Skeletal Muscle Depletion and Markers for Cancer Cachexia Are Strong Prognostic Factors in Epithelial Ovarian Cancer.Nutritional Status, Body Surface, and Low Lean Body Mass/Body Mass Index Are Related to Dose Reduction and Severe Gastrointestinal Toxicity Induced by Afatinib in Patients With Non-Small Cell Lung Cancer Sarcopenia Does Not Affect Survival or Outcomes in Soft-Tissue Sarcoma.Impact of sarcopenia on outcomes following resection of pancreatic adenocarcinoma Investigating the clinical significance of body composition changes in patients undergoing chemoradiation for oropharyngeal cancer using analytic morphomics.Morphometric age and surgical risk Using Analytic Morphomics to Understand Short-Term Convalescence after Radical Cystectomy Underweight status predicts a poor prognosis in elderly patients with colorectal cancer.Cost of major surgery in the sarcopenic patient.Skeletal Muscle Quality is Associated with Worse Survival After Pancreatoduodenectomy for Periampullary, Nonpancreatic Cancer Postoperative change of the psoas muscle area as a predictor of survival in surgically treated esophageal cancer patients Impact of sarcopenia on outcomes following intra-arterial therapy of hepatic malignancies.Low skeletal muscle radiation attenuation and visceral adiposity are associated with overall survival and surgical site infections in patients with pancreatic cancer.Skeletal muscle density is an independent predictor of diffuse large B-cell lymphoma outcomes treated with rituximab-based chemoimmunotherapy Analytic morphometric assessment of patients undergoing colectomy for colon cancer.Clinical implications of body composition assessment by computed tomography in metastatic renal cell carcinoma.Role of n-3 fatty acids in muscle loss and myosteatosis.When can nutritional therapy impact liver disease?Impact of sarcopenia in the management of urological cancer patients.A Novel Prognostic Scoring System Based on Preoperative Sarcopenia Predicts the Long-Term Outcome for Patients After R0 Resection for Gastric Cancer: Experiences of a High-Volume Center.Sarcopenia is a poor prognostic factor following hepatic resection in patients aged 70 years and older with hepatocellular carcinoma.The impact of body composition parameters on ipilimumab toxicity and survival in patients with metastatic melanoma.Prognostic Significance of Muscle Attenuation in Pancreatic Cancer Patients Treated with Neoadjuvant Chemoradiotherapy.Sarcopenia predicts survival outcomes among patients with urothelial carcinoma of the upper urinary tract undergoing radical nephroureterectomy: a retrospective multi-institution study.Sarcopenia as a predictor of pulmonary complications after esophagectomy for thoracic esophageal cancer.

P2860

Q26822365-D567FF98-6002-4979-88C9-9B3AD2CFF9A9 Q28079809-F7EE6349-954B-4347-BA40-F7E8C267F290 Q28081125-08763541-893D-41A0-AA07-51D55D81097D Q28364947-C108B63A-8BBA-4BAD-AB29-478B6B8C8CDD Q33607983-1E46BB92-00ED-4F47-8457-215F7A66B576 Q33615916-A184507F-317E-48AA-A59A-6A1D67FC6C20 Q33725992-CD311954-D4A5-4A81-8850-BB6E0455E8D7 Q34000266-A27042E9-E60B-4E62-91E1-DCDBC1D37E15 Q35001652-13252559-3379-4F17-BC37-790ECEAB9A65 Q35023332-531E1514-D422-49CF-A2FB-59F6A66FEFEC Q35096126-0327C799-E8D8-41F8-9D97-080796E1D83C Q35166583-2C4DC52B-7958-404E-A53A-4ED0078819E8 Q35662253-5D738742-F425-4090-82AA-0080544F870E Q35674557-5F646B6B-69FE-4D9E-A895-88EB14EC5B81 Q35722941-9120EF1E-B92F-487B-9336-AF8CC10D6C2D Q35803334-79B32587-DE86-4EF7-8495-D7EF49BA71A8 Q35915754-A84F46A5-EB9F-4B04-9072-116C1D23C53E Q36369039-F0825E0C-DDF1-4C76-8C92-D35DA8E2BBDA Q36626534-57D84E20-77C2-474A-9A6F-3183F4DB1EED Q36788868-1380B554-5785-4E19-8C6D-2F9EDBDBE371 Q36909688-77D7AAD0-9213-463B-A90E-7A7B9399D212 Q37053787-F1756526-ECE9-4F33-87A5-26B48EE6E179 Q37205250-717E5DC9-7D37-4607-B954-3917F1BE40DC Q37257127-2FB0B16D-B8D6-42FE-A14C-ABE90A2012DD Q37528758-EA490DC8-13C6-45E0-A129-053F4BADA9E8 Q37677642-78E32E6C-BFA6-4750-BAC7-9A22D1B21673 Q37695686-08BBA5D1-5393-4A19-AF91-2EADAFCAA273 Q37734752-099FCAC3-4787-49EA-800D-2AF2DF18E271 Q37734757-74F2E6CE-34BA-4898-B2D9-A8F6C7FE8E3B Q38121038-A73DC58E-49D6-489F-8272-F7B0BCA1A10A Q38176985-18888260-CDFF-4B25-837D-E15CAC0E08FC Q38215558-954C9D68-3533-47FC-A994-2B1B00F3DBCA Q38245694-C4ACCB47-8485-4825-9CAE-5003A68D11C4 Q38749004-729D3956-304C-4A6F-952E-C90A673D6A75 Q38954416-15C717E3-7FAF-462B-8D44-9E80C5796235 Q39994895-5C05F427-56C2-41A8-9321-92F0A3F30B6B Q40387345-B9477877-4755-4800-8A7A-E644B58D7DE6 Q40618487-7C0E930F-7568-47C1-B99D-30232D9D438E Q40648872-E9B8355D-8C63-4326-ABB3-F34AE5BDDEE8 Q40874943-23301150-EFBC-40F8-83DD-172006F91AAD

P2860

Sarcopenia as a prognostic factor among patients with stage III melanoma.

http://www.wikidata.org/entity/Q37913089

description

article científic

@ca

article scientifique

@fr

articol științific

@ro

articolo scientifico

@it

artigo científico

@gl

artigo científico

@pt

artigo científico

@pt-br

artikel ilmiah

@id

artikull shkencor

@sq

artículo científico

@es

name

Sarcopenia as a prognostic factor among patients with stage III melanoma.

@en

Sarcopenia as a prognostic factor among patients with stage III melanoma.

@nl

type

label

Sarcopenia as a prognostic factor among patients with stage III melanoma.

@en

Sarcopenia as a prognostic factor among patients with stage III melanoma.

@nl

prefLabel

Sarcopenia as a prognostic factor among patients with stage III melanoma.

@en

Sarcopenia as a prognostic factor among patients with stage III melanoma.

@nl

P1433

Q37913089-0C3C721D-1346-411D-8534-0F92B4ACB74E

P1476

Q37913089-8A50A6C3-9ACD-4B63-A6B6-EE6FAD1FF129

P2093

Q37913089-06AAFE69-6C97-48A5-B9CE-B845796731CB

Q37913089-45FF3CAC-A3F8-4F36-8BCE-E174C5C0E33C

Q37913089-AE2E9C3A-A897-4370-9588-EC29B8337A32

Q37913089-AFA11970-30CD-4F5C-92AB-94DD251AEBDB

Q37913089-C6CF2B3C-CE8F-47C8-A9CE-2C68FE2CBCDD

Q37913089-CF42993E-DA5B-4304-8ED2-58FA7814AEFF

P2860

Q37913089-04AC3519-5110-4C39-A272-B0F5A6797C38

Q37913089-09B89827-3916-41BF-9ECB-FC9ADD259451

Q37913089-10DEC396-F5E1-4179-936C-FF8240D90CE9

Q37913089-1878CBFD-7596-40A7-BC83-5443DFB32F35

Q37913089-3E2F5ED2-8BE4-4AE9-A72A-31A0B87AEAC4

Q37913089-4C00516D-437D-4266-B3D0-2C7C23D587C9

Q37913089-4CD17CB0-A529-411E-82E7-C3545728C187

Q37913089-603E39E2-FCA4-4AC0-9F10-2FA9C85FFFA5

Q37913089-6E3E0845-A6F2-4F63-9F01-ADAD618C6DD7

Q37913089-93B8871D-A876-4D72-A15D-B69E8834382F

P2888

Q37913089-2CB18F3C-A16A-422A-A7C9-6ECBC5F8F722

P304

Q37913089-8FB6B7C2-D672-4327-BD45-6F71DB52168D

P31

Q37913089-D0B8591D-47D4-4B5E-93CF-12787A1D925B

P356

Q37913089-F8F91C6E-6336-4387-B8B7-703717132455

P433

Q37913089-C7F84A8B-6B92-421B-8A27-A6988A8C4AE9

P478

Q37913089-59D6AA55-1B86-4913-985F-865DCB19FB0A

P577

Q37913089-619F753F-E711-4E3D-A261-AB3D89F37AB2

P6179

Q37913089-1AB6A889-C6B2-4178-90A3-8353D521FBA3

P698

Q37913089-F6A77A51-D49D-48A7-8D36-9ECE4DA222AA

P921

Q37913089-9175EA58-8830-48BD-AEE3-3DA73E500040

P356

S10434-011-1976-9

P1433

Annals of Surgical Oncology

P1476

Sarcopenia as a prognostic factor among patients with stage III melanoma.

@en

P2093

Jay Lee

http://www.w3.org/2001/XMLSchema#string

Michael J Englesbe

http://www.w3.org/2001/XMLSchema#string

Michael S Sabel

http://www.w3.org/2001/XMLSchema#string

Shijie Cai

http://www.w3.org/2001/XMLSchema#string

Stephen Holcombe

http://www.w3.org/2001/XMLSchema#string

Stewart Wang

http://www.w3.org/2001/XMLSchema#string

P2860

Vitamin D deficiency

Frailty in older adults: evidence for a phenotype

Frailty and activation of the inflammation and coagulation systems with and without clinical comorbidities: results from the Cardiovascular Health Study

Inflammation and immune system alterations in frailty

Review Article: Sarcopenia: Causes, Consequences, and Preventions

Adipose tissue infiltration in skeletal muscle of healthy elderly men: relationships with body composition, insulin resistance, and inflammation at the systemic and tissue level.

Vitamin D status and its relation to muscle mass and muscle fat in young women.

Adaptation to hypoxia and acidosis in carcinogenesis and tumor progression

The impact of factors beyond Breslow depth on predicting sentinel lymph node positivity in melanoma.

Melanoma development and progression: a conspiracy between tumor and host.

P2888

s10434-011-1976-9

P304

3579-3585

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1245/S10434-011-1976-9

http://www.w3.org/2001/XMLSchema#string

P433

13

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

2011-08-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1046062680

http://www.w3.org/2001/XMLSchema#string

P698

21822551

http://www.w3.org/2001/XMLSchema#string

P921